Boston Scientific Corp. (BSX)

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)

Market region: US

Address: 300 Boston Scientific Way, Marlborough, MA, 01752-1234

Market capitalization

60.84 billion USD (60,838,655,501 USD)

Listing date

05/18/1992

Weighted shares outstanding

1,449,229,526

Share class shares outstanding

1,449,229,526

https://www.bostonscientific.com